Aragen Life Sciences

Aragen operationalises first phase of its Biologics manufacturing facility in India

Executes the first project for developing and manufacturing a novel anticancer mAb 28 March 2024 – Hyderabad, India – Aragen, a leading Contract Research Development and Manufacturing Organisation (CRDMO) for small molecules and biologics, announced that it has operationalised the first phase of its biologics manufacturing facility in Bangalore, India through its 100% subsidiary, Aragen...

Aragen launches royalty-free CHO GS cell line development platform under RapTr2022

Delivers Titres up to 6g/L; Transfection to RCB in 18 weeks; RapTr2022 supports CHO GS and DG 44

Aragen to operationalize cutting-edge formulation manufacturing facility in Hyderabad, India

Facility will enhance Aragenís offerings in clinical formulation development and manufacturing Will offer both integrated and stand-alone formulations solutions to partners